Report Detail

Request for Sample of this report

Pharma & Healthcare Global Quetiapine Fumarate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4655934
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Quetiapine Fumarate market size was valued at US$ 157 million in 2024 and is forecast to a readjusted size of USD 135 million by 2031 with a CAGR of -2.1% during review period.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy"s, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
This report is a detailed and comprehensive analysis for global Quetiapine Fumarate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Quetiapine Fumarate market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Quetiapine Fumarate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Quetiapine Fumarate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Quetiapine Fumarate market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Quetiapine Fumarate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Quetiapine Fumarate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Quetiapine Fumarate market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immediate Release Tablets
Extended Release Tablets
Market segment by Application
Adult
Others
Major players covered
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quetiapine Fumarate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quetiapine Fumarate, with price, sales quantity, revenue, and global market share of Quetiapine Fumarate from 2020 to 2025.
Chapter 3, the Quetiapine Fumarate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quetiapine Fumarate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Quetiapine Fumarate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quetiapine Fumarate.
Chapter 14 and 15, to describe Quetiapine Fumarate sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Quetiapine Fumarate Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Immediate Release Tablets
    • 1.3.3 Extended Release Tablets
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Quetiapine Fumarate Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Adult
    • 1.4.3 Others
  • 1.5 Global Quetiapine Fumarate Market Size & Forecast
    • 1.5.1 Global Quetiapine Fumarate Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Quetiapine Fumarate Sales Quantity (2020-2031)
    • 1.5.3 Global Quetiapine Fumarate Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Quetiapine Fumarate Product and Services
    • 2.1.4 AstraZeneca Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Intas
    • 2.2.1 Intas Details
    • 2.2.2 Intas Major Business
    • 2.2.3 Intas Quetiapine Fumarate Product and Services
    • 2.2.4 Intas Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Intas Recent Developments/Updates
  • 2.3 TAPI
    • 2.3.1 TAPI Details
    • 2.3.2 TAPI Major Business
    • 2.3.3 TAPI Quetiapine Fumarate Product and Services
    • 2.3.4 TAPI Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 TAPI Recent Developments/Updates
  • 2.4 Accord
    • 2.4.1 Accord Details
    • 2.4.2 Accord Major Business
    • 2.4.3 Accord Quetiapine Fumarate Product and Services
    • 2.4.4 Accord Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Accord Recent Developments/Updates
  • 2.5 Hexal
    • 2.5.1 Hexal Details
    • 2.5.2 Hexal Major Business
    • 2.5.3 Hexal Quetiapine Fumarate Product and Services
    • 2.5.4 Hexal Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hexal Recent Developments/Updates
  • 2.6 Dr.Reddy's
    • 2.6.1 Dr.Reddy's Details
    • 2.6.2 Dr.Reddy's Major Business
    • 2.6.3 Dr.Reddy's Quetiapine Fumarate Product and Services
    • 2.6.4 Dr.Reddy's Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Dr.Reddy's Recent Developments/Updates
  • 2.7 Lupin
    • 2.7.1 Lupin Details
    • 2.7.2 Lupin Major Business
    • 2.7.3 Lupin Quetiapine Fumarate Product and Services
    • 2.7.4 Lupin Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Lupin Recent Developments/Updates
  • 2.8 Sun Pharmaceutical
    • 2.8.1 Sun Pharmaceutical Details
    • 2.8.2 Sun Pharmaceutical Major Business
    • 2.8.3 Sun Pharmaceutical Quetiapine Fumarate Product and Services
    • 2.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Sun Pharmaceutical Recent Developments/Updates
  • 2.9 Hunan Dongting Pharm
    • 2.9.1 Hunan Dongting Pharm Details
    • 2.9.2 Hunan Dongting Pharm Major Business
    • 2.9.3 Hunan Dongting Pharm Quetiapine Fumarate Product and Services
    • 2.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Hunan Dongting Pharm Recent Developments/Updates
  • 2.10 SuZhou NO.4 Phamaceutical Factory
    • 2.10.1 SuZhou NO.4 Phamaceutical Factory Details
    • 2.10.2 SuZhou NO.4 Phamaceutical Factory Major Business
    • 2.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product and Services
    • 2.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
  • 2.11 Fuan Pharmaceutical
    • 2.11.1 Fuan Pharmaceutical Details
    • 2.11.2 Fuan Pharmaceutical Major Business
    • 2.11.3 Fuan Pharmaceutical Quetiapine Fumarate Product and Services
    • 2.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Fuan Pharmaceutical Recent Developments/Updates
  • 2.12 Zhejiang Supor Pharmaceuticals
    • 2.12.1 Zhejiang Supor Pharmaceuticals Details
    • 2.12.2 Zhejiang Supor Pharmaceuticals Major Business
    • 2.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product and Services
    • 2.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates
  • 2.13 Zhejiang Huahai Pharmaceutical
    • 2.13.1 Zhejiang Huahai Pharmaceutical Details
    • 2.13.2 Zhejiang Huahai Pharmaceutical Major Business
    • 2.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product and Services
    • 2.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Quetiapine Fumarate by Manufacturer

  • 3.1 Global Quetiapine Fumarate Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Quetiapine Fumarate Revenue by Manufacturer (2020-2025)
  • 3.3 Global Quetiapine Fumarate Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Quetiapine Fumarate by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Quetiapine Fumarate Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Quetiapine Fumarate Manufacturer Market Share in 2024
  • 3.5 Quetiapine Fumarate Market: Overall Company Footprint Analysis
    • 3.5.1 Quetiapine Fumarate Market: Region Footprint
    • 3.5.2 Quetiapine Fumarate Market: Company Product Type Footprint
    • 3.5.3 Quetiapine Fumarate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Quetiapine Fumarate Market Size by Region
    • 4.1.1 Global Quetiapine Fumarate Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Quetiapine Fumarate Consumption Value by Region (2020-2031)
    • 4.1.3 Global Quetiapine Fumarate Average Price by Region (2020-2031)
  • 4.2 North America Quetiapine Fumarate Consumption Value (2020-2031)
  • 4.3 Europe Quetiapine Fumarate Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Quetiapine Fumarate Consumption Value (2020-2031)
  • 4.5 South America Quetiapine Fumarate Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Quetiapine Fumarate Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 5.2 Global Quetiapine Fumarate Consumption Value by Type (2020-2031)
  • 5.3 Global Quetiapine Fumarate Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 6.2 Global Quetiapine Fumarate Consumption Value by Application (2020-2031)
  • 6.3 Global Quetiapine Fumarate Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 7.2 North America Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 7.3 North America Quetiapine Fumarate Market Size by Country
    • 7.3.1 North America Quetiapine Fumarate Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Quetiapine Fumarate Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 8.2 Europe Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 8.3 Europe Quetiapine Fumarate Market Size by Country
    • 8.3.1 Europe Quetiapine Fumarate Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Quetiapine Fumarate Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Quetiapine Fumarate Market Size by Region
    • 9.3.1 Asia-Pacific Quetiapine Fumarate Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Quetiapine Fumarate Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 10.2 South America Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 10.3 South America Quetiapine Fumarate Market Size by Country
    • 10.3.1 South America Quetiapine Fumarate Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Quetiapine Fumarate Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Quetiapine Fumarate Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Quetiapine Fumarate Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Quetiapine Fumarate Market Size by Country
    • 11.3.1 Middle East & Africa Quetiapine Fumarate Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Quetiapine Fumarate Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Quetiapine Fumarate Market Drivers
  • 12.2 Quetiapine Fumarate Market Restraints
  • 12.3 Quetiapine Fumarate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Quetiapine Fumarate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Quetiapine Fumarate
  • 13.3 Quetiapine Fumarate Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Quetiapine Fumarate Typical Distributors
  • 14.3 Quetiapine Fumarate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Quetiapine Fumarate. Industry analysis & Market Report on Quetiapine Fumarate is a syndicated market report, published as Global Quetiapine Fumarate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Quetiapine Fumarate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo